Literature DB >> 25869596

Ginkgolide B Protects Neurons from Ischemic Injury by Inhibiting the Expression of RTP801.

Xiaomei Wu1, Jianyou Su2, Lei Chen1, Baodong Ma1, Xiaosu Gu3, Li Zhu4.   

Abstract

RTP801 (also known as REDD1), a stress-related protein, is induced by several environmental stresses such as ischemia and cigarette smoke. Although ischemia can dramatically up-regulate RTP801 expression in brain ischemia, up to now, the exact relation between RTP801 and neuronal death in ischemia is poorly understood. In the current study, using oxygen and glucose deprivation as an in vitro ischemic model in primary cultured cortical neurons, we found that the expression of RTP801 increased progressively with prolongation of ischemic duration, in which the expression of RTP801 is positively correlated with the release of lactate dehydrogenase (LDH) in neurons, and knockdown of RTP801 promoted neuronal survival in ischemia-reperfusion. It was further found that ginkgolide B (GB) could significantly increase cell viability and decrease LDH release, and at the same time reduce the levels of RTP801 mRNA and protein in neurons after ischemia and reperfusion. Moreover, GB-induced reduction in expression of RTP801 was blocked by application of LY294002, a specific inhibitor of phosphatidylinositol 3-kinase (PI3K). These results demonstrate that RTP801 could play a detrimental role on neurons in ischemia, and GB might protect neurons against ischemic injury by inhibiting RTP801 expression via PI3K pathway.

Entities:  

Keywords:  Ginkgolide B; Ischemia; Ischemia–Reperfusion; Neuron; Phosphatidylinositol 3-kinase; RTP801

Mesh:

Substances:

Year:  2015        PMID: 25869596     DOI: 10.1007/s10571-015-0189-3

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  28 in total

1.  Nonselective inhibition by antisense oligonucleotides of cytosine arabinoside action.

Authors:  H Manev; S Caredda; D R Grayson
Journal:  Neuroreport       Date:  1991-10       Impact factor: 1.837

2.  Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis.

Authors:  Tzipora Shoshani; Alexander Faerman; Igor Mett; Elena Zelin; Tamar Tenne; Svetlana Gorodin; Yana Moshel; Shlomo Elbaz; Andrei Budanov; Ayelet Chajut; Hagar Kalinski; Iris Kamer; Ada Rozen; Orna Mor; Eli Keshet; Dena Leshkowitz; Paz Einat; Rami Skaliter; Elena Feinstein
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

3.  Ginkgo biloba extract increases ocular blood flow velocity.

Authors:  H S Chung; A Harris; J K Kristinsson; T A Ciulla; C Kagemann; R Ritch
Journal:  J Ocul Pharmacol Ther       Date:  1999-06       Impact factor: 2.671

4.  Oxygen-sensitive {delta}-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection.

Authors:  Ming-Chieh Ma; Hong Qian; Farshid Ghassemi; Peng Zhao; Ying Xia
Journal:  J Biol Chem       Date:  2005-02-01       Impact factor: 5.157

5.  Platelet-activating factor antagonists protect amyloid-beta damaged neurons from microglia-mediated death.

Authors:  Clive Bate; Sarah Kempster; Alun Williams
Journal:  Neuropharmacology       Date:  2006-05-05       Impact factor: 5.250

Review 6.  The CNS effects of Ginkgo biloba extracts and ginkgolide B.

Authors:  Karyn M Maclennan; Cynthia L Darlington; Paul F Smith
Journal:  Prog Neurobiol       Date:  2002-06       Impact factor: 11.685

7.  Ginkgolide B preconditioning on astrocytes promotes neuronal survival in ischemic injury via up-regulating erythropoietin secretion.

Authors:  Xiaomei Wu; Cheng Zhou; Fang Du; Yapeng Lu; Bin Peng; Lei Chen; Li Zhu
Journal:  Neurochem Int       Date:  2012-11-28       Impact factor: 3.921

8.  RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation.

Authors:  Cristina Malagelada; Zong Hao Jin; Lloyd A Greene
Journal:  J Neurosci       Date:  2008-12-31       Impact factor: 6.167

9.  Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761.

Authors:  Yuan Luo; Julie V Smith; Vijaykumar Paramasivam; Adam Burdick; Kenneth J Curry; Justin P Buford; Ikhlas Khan; William J Netzer; Huaxi Xu; Peter Butko
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-04       Impact factor: 11.205

10.  Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.

Authors:  James Brugarolas; Kui Lei; Rebecca L Hurley; Brendan D Manning; Jan H Reiling; Ernst Hafen; Lee A Witters; Leif W Ellisen; William G Kaelin
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

View more
  5 in total

1.  Identification of ginkgolide targets in brain by photoaffinity labeling.

Authors:  Akira Kawamura; Ilyas Washington; Doina M Mihai; Francesca Bartolini; Gregg G Gundersen; Milica Tesic Mark; Koji Nakanishi
Journal:  Chem Biol Drug Des       Date:  2016-11-10       Impact factor: 2.817

2.  Time-Course Change of Redd1 Expressions in the Hippocampal CA1 Region Following Chronic Cerebral Hypoperfusion.

Authors:  Jin-A Park; Choong-Hyun Lee
Journal:  Cell Mol Neurobiol       Date:  2016-05-27       Impact factor: 5.046

3.  Salvianolic Acid B Ameliorates Cerebral Ischemia/Reperfusion Injury Through Inhibiting TLR4/MyD88 Signaling Pathway.

Authors:  Yujue Wang; Guang Chen; Xiangdong Yu; Yunchao Li; Li Zhang; Zongze He; Nannan Zhang; Xiuping Yang; Yansheng Zhao; Na Li; Hong Qiu
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

4.  Ginkgolide B promotes the proliferation and differentiation of neural stem cells following cerebral ischemia/reperfusion injury, both in vivo and in vitro.

Authors:  Pei-Dong Zheng; Rajneesh Mungur; Heng-Jun Zhou; Muhammad Hassan; Sheng-Nan Jiang; Jie-Sheng Zheng
Journal:  Neural Regen Res       Date:  2018-07       Impact factor: 5.135

Review 5.  The neuroprotective mechanisms of ginkgolides and bilobalide in cerebral ischemic injury: a literature review.

Authors:  Zili Feng; Qian Sun; Wang Chen; Yu Bai; Daihua Hu; Xin Xie
Journal:  Mol Med       Date:  2019-12-21       Impact factor: 6.354

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.